Sipuleucel-T in Metastatic Castration-Resistant Prostate Concert Profile Report

被引：2
|
作者：
Plosker, Greg L. [1 ]
机构：
[1] Adis Int Ltd, Auckland 0754, New Zealand
来源：
BIODRUGS | 2011年 / 25卷 / 04期
关键词：
CANCER; IMMUNOTHERAPY; MITOXANTRONE; PREDNISONE; DOCETAXEL;
D O I：
10.2165/11207140-000000000-00000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [21] Durable Complete Remission From Castration-Resistant Prostate Cancer With Sipuleucel-T After Estrogen Withdrawal
    Dorff, Tanya B.
    Wilkins, Cy
    Hepgur, Mehmet
    Quinn, David I.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (02) : E55 - E58
  • [22] Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
    Bilen, Mehmet Asim
    Hess, Kenneth R.
    Subudhi, Sumit K.
    Aparicio, Ana
    Kim, Jeri
    Zurita-Saavedra, Amado J.
    Araujo, John C.
    Corn, Paul G.
    Stover, Jessica
    Lin, Sue-Hwa
    Logothetis, Christopher J.
    Tu, Shi-Ming
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 583 - 589
  • [23] Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
    Mehmet Asim Bilen
    Kenneth R. Hess
    Sumit K. Subudhi
    Ana Aparicio
    Jeri Kim
    Amado J. Zurita-Saavedra
    John C. Araujo
    Paul G. Corn
    Jessica Stover
    Sue-Hwa Lin
    Christopher J. Logothetis
    Shi-Ming Tu
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 583 - 589
  • [24] Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T
    Small, E. J.
    Higano, C. S.
    Kantoff, P. W.
    Whitmore, J. B.
    Frohlich, M. W.
    Petrylak, D. P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (03) : 259 - 264
  • [25] Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry
    Wei, Xiao X.
    Kwak, Lucia
    Hamid, Anis
    He, Monica
    Sweeney, Christopher
    Flanders, Scott C.
    Harmon, Matthew
    Choudhury, Atish D.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (02) : 314 - 319
  • [26] Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
    Sinha, Meenal
    Zhang, Li
    Subudhi, Sumit
    Chen, Brandon
    Marquez, Jaqueline
    Liu, Eric V.
    Allaire, Kate
    Cheung, Alexander
    Ng, Sharon
    Nguyen, Christopher
    Friedlander, Terence W.
    Aggarwal, Rahul
    Spitzer, Matthew
    Allison, James P.
    Small, Eric J.
    Sharma, Padmanee
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [27] IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Pachynski, Russell K.
    Morishima, Chihiro
    Szmulewitz, Russell
    Harshman, Lauren
    Appleman, Leonard
    Monk, Paul
    Bitting, Rhonda L.
    Kucuk, Omer
    Millard, Frederick
    Seigne, John D.
    Fling, Steven P.
    Maecker, Holden T.
    Duault, Caroline
    Ramchurren, Nirasha
    Hess, Bruce
    D'Amico, Leonard
    Lacroix, Andreanne
    Kaiser, Judith C.
    Morre, Michel
    Gregoire, Anne
    Cheever, Martin
    Yu, Evan Y.
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
  • [28] A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
    Small, Eric J.
    Lance, Raymond S.
    Gardner, Thomas A.
    Karsh, Lawrence I.
    Fong, Lawrence
    Mccoy, Candice
    DeVries, Todd
    Sheikh, Nadeem A.
    Thakurta, Debraj Guha
    Chang, Nancy
    Redfern, Charles H.
    Shore, Neal D.
    CLINICAL CANCER RESEARCH, 2015, 21 (17) : 3862 - 3869
  • [29] Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
    Marshall, Catherine H.
    Fu, Wei
    Wang, Hao
    Park, Jong Chul
    DeWeese, Theodore L.
    Tran, Phuoc T.
    Song, Daniel Y.
    King, Serina
    Afful, Michaella
    Hurrelbrink, Julia
    Manogue, Charlotte
    Cotogno, Patrick
    Moldawer, Nancy P.
    Barata, Pedro C.
    Drake, Charles G.
    Posadas, Edwin M.
    Armstrong, Andrew J.
    Sartor, Oliver
    Antonarakis, Emmanuel S.
    CLINICAL CANCER RESEARCH, 2021, 27 (06) : 1623 - 1630
  • [30] Sipuleucel-T for the treatment of metastatic prostate cancer Promise and challenges
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) : 509 - 519
12345